• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cromos Pharma launches risk-sharing partnerships program

Cromos Pharma launches risk-sharing partnerships program

December 19, 2014
CenterWatch Staff

Portland, Ore.-based CRO Cromos Pharma, which operates predominantly in Eastern/Central Europe, has implemented a risk-sharing platform partnering with biotech, pharma and device companies with promising drug, biologics or medical device technologies.

Cromos Pharma offers several unique business partnership algorithms through its risk-sharing model, including clinical research program conduct in exchange for equity or licensing opportunities.

"I have been intimately involved in the formation of a biotechnology company and understand how difficult it is to raise sufficient funds even for the most exciting and ground-breaking medical discoveries," said Dr. Vlad Bogin, Cromos Pharma's CEO. "Cromos Pharma has experienced steady and sustained growth and now is positioned to offer companies with promising clinical programs mutually beneficial partnership algorithms."

"Over the years we have been approached by a number of biotech companies with compelling technologies," said Dr. Andrey Tarakanov, the company's managing director. "Cromos Pharma's team would be asked to develop a trial protocol or perform a feasibility study, but then the process would stall due to that company's financial constraints."

"We want to change this paradigm and help the companies advance the science we believe in," said Bogin. "Cromos Pharma's team is experienced in clinical research, biopharmacology and medicine—this expertise and our state-of-the-art facilities uniquely position Cromos Pharma to accurately evaluate medical technologies and select the best partners."

Cromos Pharma, founded in 2004, manages phase I-IV clinical trials in Belarus, Bulgaria, Czech Republic, Estonia, Georgia, Hungary, Israel, Latvia, Lithuania, Moldova, Poland, Romania, Russia, Slovakia and Ukraine, with corporate headquarters in the U.S. and business development offices in Ireland. In 2011, Cromos Pharma and two other Russian companies joined forces by creating a strategic partnership—3C Alliance—that provides an unprecedented scope of services to the Russian clinical trials market.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing